# Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet

> **NCT03817619** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Hepatitis C
- Deglutition Disorders

## Interventions

- **DRUG:** Zepatier whole tablet
- **DRUG:** Zepatier crushed tablet

## Key facts

- **NCT ID:** NCT03817619
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-28
- **Primary completion:** 2019-07-30
- **Final completion:** 2019-07-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03817619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03817619, "Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03817619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*